Hyderabad-based Bharat Biotech said its Covid-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.

"Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the Company`s Investigational New Drug application (IND) to evaluate the Covid-19 vaccine candidate, BBV152, known as Covaxin outside the United States. Ocugen, Inc is co-developing Bharat Biotech`s Covaxin vaccine candidate for Covid-19 in USA and Canada," reads Bharat Biotech`s statement.